Dr. Peter Martin, AbbVie, and the Werner Family to be recognized at November 13 event in New York City

NEW YORK, November 12, 2026 – The Lymphoma Research Foundation today announced the honorees for its 2026 Annual Gala, taking place Friday, Nov. 13 at the Ziegfeld Ballroom in New York City.

The Foundation will honor Dr. Peter Martin, AbbVie and the Werner Family. The gala is the Foundation’s largest fundraising event. Last year, the gala raised more than $1.4 million to support its mission to eradicate lymphoma and serve those impacted by the disease.

“The progress we have made for people affected by lymphoma and CLL is possible because of the extraordinary commitment of researchers, clinicians, patients, families and partners who believe in our mission,” said Meghan Gutierrez, Lymphoma Research Foundation’s Chief Executive Officer. “Our gala gives us an opportunity to recognize individuals and organizations whose contributions have strengthened our community, while raising the critical funds that allow us to invest in promising research and provide support to people affected by lymphoma.”

Dr. Peter Martin, a hematologist-oncologist at NYU Langone Health, will receive the Distinguished Leadership Award for his scientific and clinical leadership in lymphoma care and research, notably his work to advance new treatment approaches and improve outcomes for people with lymphoma.

The Werner Family will receive the Legacy Award, recognizing their commitment to supporting lymphoma research after Michael Werner’s diagnosis. The Werners have become dedicated philanthropic supporters of research and the lymphoma community.

AbbVie will receive the Corporate Leadership Award, honoring the company’s outstanding commitment to advancing lymphoma research and supporting the lymphoma community through sustained investments in scientific programming and its dedication to expanding patient education and care.

“Receiving this recognition from the Lymphoma Research Foundation is a tremendous honor. It reflects AbbVie’s long-standing commitment of advancing lymphoma research and science to develop  innovative therapies for people living with blood cancer,” said Svetlana Kobina, Vice President, Global Media Affairs, Oncology at AbbVie. “We are proud to work alongside patients, researchers, healthcare professionals and advocacy organizations like the Foundation whose continued partnership help us drive meaningful progress for the lymphoma community.”

WHAT: Lymphoma Research Foundation’s 2026 Annual Gala

WHEN: Friday, November 13, 2026

WHERE: Ziegfeld Ballroom, 141 W 54th Street, New York, New York 10019

About the Lymphoma Research Foundation:

The Foundation is the nation’s largest nonprofit organization devoted exclusively to funding innovative lymphoma research and serving those who have had lymphoma and the health care providers, family and friends who help care for lymphoma patients. The Foundation supports the community through a comprehensive series of education programs, outreach initiatives, and patient services. For more information about the Lymphoma Research Foundation and the latest on lymphoma treatment, patient care and scientific research, visit  lymphoma.org. For more information on the Lymphoma Research Foundation’s Board of Directors, visit https://lymphoma.org/bod/. Connect with us on Facebook, X, YouTube, Instagram, and LinkedIn.